c-erbB-2 in bladder cancer: Molecular biology, correlation with epidermal growth factor receptors and prognostic value

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 321-326

  Mellon, J Kilian ^a   Lunec, John ^b   Wright, Chris ^b   Horne, C H Wilson ^b   Kelly, Peter ^b   Neal, David E ^b  

^a CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

Bladder neoplasms; Growth substances; Oncogenes; Proto oncogene proteins c erbB 2

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; ONCOPROTEIN;

ARTICLE; BLADDER CANCER; CANCER STAGING; CELL ONCOGENE; CONTROLLED STUDY; DNA DETERMINATION; DOT HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TUMOR RECURRENCE;

BLADDER; BLADDER NEOPLASMS; BLOTTING, SOUTHERN; CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; GENE EXPRESSION; GENES, ERBB-2; HUMAN; IMMUNOBLOTTING; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS V-ERBB; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T;

EID: 0029655413     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66653-9     Document Type: Article

References (30)

1. Bargmann, C. I., Hung, M.-C. and Weinberg, R. A.: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319: 226, 1986.
2. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T. and Toyoshima, K.: Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature, 319: 230, 1986.
3. Stern, D. F., Heffernan, P. A. and Weinberg, R. A.: p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol., 6: 1729, 1986.
4. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K. and Yamamoto, T.: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science, 232: 1644, 1986.
5. Lee, J., Dull, T. J., Lax, I., Schlessinger, J. and Ullrich, A.: HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. E.M.B.O.J., 8: 167, 1989.
6. Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., Koski, R. A., Hsieng, S. L. and Yarden, Y.: Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69: 559, 1992.
7. Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., Shephard, H. M., Kuang, W. -J., Wood, W. I., Goeddel, D. V. and Vandlen, R. L.: Identification of heregulin, a specific activator of p185erbB2. Science, 256: 1205, 1992.
8. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J. and Shoyab, M.: Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. U.S.A., 87: 4905, 1990.
9. Plowman, G. D., Culouscou, J.-M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G. and Shoyab, M.: Ligand specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. U.S.A., 90: 1746, 1993.
10. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A. and Press, M. F.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244: 707, 1989.
11. Borg, A., Baldetorp, B., Ferno, M., Killander, D., Olsson, H. and Sigurdsson, H.: ERBB-2 amplification in breast cancer with a high rate of proliferation. Oncogene, 6: 137, 1991.
12. Wright, C., Mellon, K., Neal, D. E., Johnston, P., Corbett, I. P. and Home, C. H. W.: Expression of c-erbB-2 protein product in bladder cancer. Br. J. Cancer, 62: 764, 1990.
13. McCann, A., Dervan, P. A., Johnston, P. A., Gullick, W. J. and Carney, D. N.: c-erbB-2 oncoprotein expression in primary human tumours. Cancer, 65: 88, 1990.
14. Asamoto, M., Hasegawa, R., Masuko, T., Hashimoto, Y., Ueda, K., Ohtaguro, K., Sasaki, S., Washida, H. and Fukushima, S.: Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas. Acta Pathol. Jpn., 40: 322, 1990.
15. Wright, C., Mellon, K., Johnston, P., Lane, D. P., Harris, A. L., Home, C. H. W. and Neal, D. E.: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br. J. Cancer, 63: 967, 1991.
16. Moriyama, M., Akiyama, T., Yamamoto, T., Kawamoto, T., Kato, T., Sato, K., Watanuki, T., Hikage, T., Katsuta, N. and Mori, S.: Expression of c-erbB-2 gene product in urinary bladder cancer. J. Urol., 145: 423, 1991.
17. Coombs, L. M., Pigott, D. A., Sweeney, E., Proctor, A. J., Eydmann, M. E., Parkinson, C. and Knowles, M. A.: Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer, 63: 601, 1991.
18. Zhau, H. E., Zhang, X., von Eschenbach, A. C., Scorsone, K., Babaian, R. J., Ro, J. Y. and Hung, M. C.: Amplification and expression of the c-erbB-2/neu proto-oncogene in human bladder cancer. Mol. Carcinog., 3: 254, 1990.
19. Sauter, G., Moch, H., Moore, D., Carroll, P., Kerschmann, R., Chew, K., Mihatsch, M. J., Gudat, P. and Waldeman, F.: Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res. 53: 2199, 1993.
20. Corbett, I. P., Henry, J. A., Angus, B., Watchhorn, C. J., Wilkinson, L., Hennessey, C., Gullick, W. J., Tuzi, N. L., May, F. E. B., Westley, B. R. and Horne, C. H. W.: NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J. Pathol., 161: 15, 1990.
21. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1986.
22. Mason, P. J. and Williams, J. G.: Hybridisation and analysis of recombinant DNA. In: Nucleic Acid Hybridisation: A Practical Approach. Edited by B. D. Hames and S. J. Higgins. Oxford: IRL Press, 1985.
23. Feinberg, A. P. and Vogelstein, B.: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6, 1983.
24. Jakse, G., Loidl, W., Seeber, G. and Hofstädter, F.: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J. Urol., 137: 39, 1987.
25. Cox, D. R.: Regression models and life tables. J. R. Statist. Soc. B, 34: 187, 1972.
26. Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B. and Waterfield, M. D.: Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40: 246, 1987.
27. Venter, D. J., Tuzi, N. L., Kumar, S. and Gullick, W. J.: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet, II: 69, 1987.
28. Berger, M. S., Greenfield, C., Gullick, W. J., Haley, J., Downward, J., Neal, D. E., Harris, A. L. and Waterfield, M. D.: Evaluation of epidermal growth factor receptors in bladder tumours. Br. J. Cancer, 56: 533, 1987.
29. Hudziak, R. M., Lewis, G. D., Winget, M., Fendly, B. M., Shepard, H. M. and Ullrich, A.: p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol., 9: 1165, 1989.
30. Lofts, F. J., Hurst, H. C., Sternberg, M. J. and Gullick, W. J.: Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo. Oncogene, 8: 2813, 1993.